Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00471042 · ClinicalTrials.gov registry record
Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care
A clinical trial, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 30
- Enrollment target
NCT00471042 is a clinical trial that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 30 participants.
The verdict
NCT00471042 has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this treatment research study is to assess the effectiveness of buprenorphine maintenance treatment for opioid dependence delivered in a primary care clinic setting. This study will determine whether buprenorphine treatment in primary care is effective in reducing cravings, reducing illicit opioid use, reducing addiction severity, and retaining patients in primary care treatment for opioid dependence.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-06 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00471042
The ClinicalTrials.gov registry entry for NCT00471042 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00471042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00471042 about?
NCT00471042 is a clinical study titled "Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care". The purpose of this treatment research study is to assess the effectiveness of buprenorphine maintenance treatment for opioid dependence delivered in a primary care clinic setting. This study will determine whether buprenorphine treatment in primary care is effective in reducing cravings, reducing i...
What is the current status of trial NCT00471042?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2006-06. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00471042?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00471042?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.